as on
| Source : NSE
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
0.52%
Downside
2.51%
Upside
52 Week's Low
52 Week's High
8.40%
Downside
157.58%
Upside
Market Stats | |
Previous Close | ₹150.82 |
Open | ₹153.35 |
Volume | 13.22K |
Upper Circuit | ₹165.90 |
Lower Circuit | ₹135.73 |
Day's Low | ₹150 |
Day's High | ₹154.58 |
52 Week Low | ₹138.13 |
52 Week High | ₹388.4 |
Returns % | |
1 Month Return | -19.81 % |
3 Month Return | + 0.48 % |
1 Year Return | -45.01 % |
3 Year Return | + 242 % |
5 Year Return | + 662.1 % |
Check Indo US Bio-Tech Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹302.42 Cr
Return on Equity (ROE)
14.07
PE Ratio (TTM)
0Return on capital employed (ROCE)
14.18
Beta (LTM)
0.9
P/B Ratio
7.09
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
48.26
EPS (TTM)
2.76
Sector
FMCG
Book Value
21.01
Technical Analysis
Bearish
View Technical Analysis
Get the annual and quarterly financial summary of Indo US Bio-Tech Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Indo US Bio-Tech Ltd.
Indo US Bio-Tech Ltd’s net profit jumped 48.26% since last year same period to ₹4.70Cr in the Q1 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 27.72% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2024, Indo US Bio-Tech Ltd has declared dividend of ₹0.25 per share on 21 Nov 2024 - translating a dividend yield of 0.17%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Indo US Bio-Tech Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 70.17% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 29.83% | 0.00 | |
Others | 0% |
Compare market cap, revenue, PE, and other key metrics of Indo US Bio-Tech Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 302.42 | 132.42% | 0.00 | 5 | 50 | |
NA | 8,342.99 | 116.42% | 0.76 | 109 | 770 | |
NA | 21.48 | -8.35% | 0.00 | 1 | 3 | |
NA | 258.86 | 135.05% | 0.00 | 1 | 76 | |
NA | 127.35 | 11.91% | 0.00 | -2 | 1 |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Vimta Labs Ltd has given 171.3% return, outperforming this stock by 216.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.17% of holdings in Jun 2025 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 29.83% of holdings in Jun 2025 quarter
Against Peers
In the last 3 years, Vimta Labs Ltd has given 271.2% return, outperforming this stock by 29.2%
Price Dip
In the last 7 days, INDOUS stock has moved down by -4.0%
Organisation | Indo US Bio-Tech Ltd |
Industry | FMCG |
CEO | Jagdish Ajudia |
E-voting on shares | Click here to vote |
Indo US Bio-Tech Ltd share price today stands at ₹150.79, Open: ₹153.35, Previous Close: ₹150.82, High: ₹154.58, Low: ₹150, 52 Week High: ₹388.4, 52 Week Low: ₹138.13 as on .
To buy Indo US Bio-Tech Ltd shares, you need to follow these steps:
Today's traded volume of Indo US Bio-Tech Ltd is 13.22K. Which means that 13.22K shares of Indo US Bio-Tech Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Indo US Bio-Tech Ltd is ₹302.42 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Indo US Bio-Tech Ltd’s 52 week high is ₹388.4 and 52 week low is ₹138.13. The current share price of Indo US Bio-Tech Ltd is ₹150.79, which is -61.18% down from its 52 week high and 9.17% up from its 52 week low.